Skip to content

Effect of dural ischemia factor expression on collateral vessel formation in patients with moyamoya disease

Effect of dural ischemia factor expression on collateral vessel formation in patients with moyamoya disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400083892
Enrollment
Unknown
Registered
2024-05-07
Start date
2024-05-07
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Moyamoya disease

Interventions

Experimental group:None
control group:None

Sponsors

The First Affiliated Hospital of Zunyi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Older than 5 years old and less than 55 years old, willing to participate in this trial and sign informed consent after communication;2. All selected moyamoya disease patients were diagnosed with moyamoya disease according to cerebral angiography data;3. The selected group of patients with hypertensive intracerebral hemorrhage or unruptured aneurysm underwent imaging examination to confirm hypertensive intracerebral hemorrhage or confirmed intracranial unruptured aneurysm according to cerebral angiography data and required surgical treatment;4. All selected moyamoya disease patients received brain-dural-arterial vascular fusion;5. No infection, Immune system diseases and neoplastic diseases;6. Complete clinical data.

Exclusion criteria

Exclusion criteria: Exclude moyamoya syndrome; Severe heart, lung, liver and kidney insufficiency; The clinical data are incomplete.

Design outcomes

Primary

MeasureTime frame
HIF-1;Cav-1;

Countries

China

Contacts

Public ContactRan Qishan

The First Affiliated Hospital of Zunyi Medical University

ranqishan@126.com+86 139 8524 7021

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026